Oligodendroglioma with ganglioglioma like differentiation: management and prognostic implications. Is a WHO classification update required?

J Neurosurg Sci

Division of Neurosurgery, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, IRCCS San Martino University Hospital, University of Genoa, Genoa, Italy.

Published: December 2020

Download full-text PDF

Source
http://dx.doi.org/10.23736/S0390-5616.19.04798-2DOI Listing

Publication Analysis

Top Keywords

oligodendroglioma ganglioglioma
4
ganglioglioma differentiation
4
differentiation management
4
management prognostic
4
prognostic implications
4
implications classification
4
classification update
4
update required?
4
oligodendroglioma
1
differentiation
1

Similar Publications

Intra-axial cortical-based tumours are rare tumours affecting children and young adults. These tumours can be classified as either low-grade or high-grade, depending on their aggressiveness and rate of growth. We report a case of homonymous hemianopia secondary to an intra-axial cortical-based tumour in a young patient.

View Article and Find Full Text PDF

The 2021 World Health Organization (WHO) classification of the central nervous system (CNS) tumors has classified diffuse leptomeningeal glioneuronal tumor (DLGNT) as a mixed neuronal and glial tumor. Here, we report a DLGNT with two distinct morphological tumor components but identical molecular features. A four-year-old female child presented with progressive right upper extremity weakness.

View Article and Find Full Text PDF

:: fusion is a driver, potentially targetable, genetic alteration identified in approximately 4% of high-grade diffuse gliomas and rare cases with low-grade histology. Herein, we review the genetic and epigenetic features of these tumors and highlight the challenges in their classification and grading. Diffuse gliomas with :: fusion display unique histopathological and molecular features, including an oligodendroglioma-like appearance, calcifications, and CD34 extravascular immunoreactivity.

View Article and Find Full Text PDF

Purpose: The primary aim was to evaluate whether anti-3-[F]FACBC PET combined with conventional MRI correlated better with histomolecular diagnosis (reference standard) than MRI alone in glioma diagnostics. The ability of anti-3-[F]FACBC to differentiate between molecular and histopathological entities in gliomas was also evaluated.

Methods: In this prospective study, patients with suspected primary or recurrent gliomas were recruited from two sites in Norway and examined with PET/MRI prior to surgery.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!